Growth Metrics

Trinity Biotech (TRIB) Inventory (2016 - 2025)

Trinity Biotech's Inventory history spans 17 years, with the latest figure at $18.8 million for Q4 2025.

  • On a quarterly basis, Inventory fell 2.82% to $18.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $18.8 million, a 2.82% decrease, with the full-year FY2025 number at $18.8 million, down 2.82% from a year prior.
  • Inventory hit $18.8 million in Q4 2025 for Trinity Biotech, down from $20.1 million in the prior quarter.
  • Over the last five years, Inventory for TRIB hit a ceiling of $37.6 million in Q1 2021 and a floor of $1.2 million in Q4 2023.
  • Historically, Inventory has averaged $23.9 million across 5 years, with a median of $22.6 million in 2023.
  • Biggest five-year swings in Inventory: tumbled 94.85% in 2023 and later soared 1570.17% in 2024.
  • Tracing TRIB's Inventory over 5 years: stood at $29.1 million in 2021, then decreased by 22.73% to $22.5 million in 2022, then tumbled by 94.85% to $1.2 million in 2023, then soared by 1570.17% to $19.4 million in 2024, then decreased by 2.82% to $18.8 million in 2025.
  • Business Quant data shows Inventory for TRIB at $18.8 million in Q4 2025, $20.1 million in Q2 2025, and $19.4 million in Q4 2024.